Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lorenzo Tarli"'
Autor:
Rossana Cecere, Fabio Pasqualini, Stefano Signorini, Giuseppe Peri, Roberto Latini, Alberto Mantovani, Donata Lucci, Carlo Schweiger, Lorenzo Tarli, Paolo Mocarelli, Gianni Tognoni, Claudio Fresco, Lucio Gonzini, Aldo P. Maggioni, Luca Vago, Dario Soldateschi
Publikováno v:
Circulation. 110:2349-2354
Background— Inflammation has a pathogenetic role in acute myocardial infarction (MI). Pentraxin-3 (PTX3), a long pentraxin produced in response to inflammatory stimuli and highly expressed in the heart, was shown to peak in plasma ≈7 hours after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59877c15f123f91f700982124b8458a2
https://doi.org/10.1161/01.cir.0000145167.30987.2e
https://doi.org/10.1161/01.cir.0000145167.30987.2e
Publikováno v:
Advanced Drug Delivery Reviews. 43:165-196
One way to improve the selectivity of therapeutic molecules in clinical oncology would be to target them on the tumour site, thereby sparing normal tissues. The development of targeted therapeutic methodologies relies in most cases on the availabilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d1ff6f0c64d3bdd6e020161b2105d71
https://doi.org/10.1016/s0169-409x(00)00068-5
https://doi.org/10.1016/s0169-409x(00)00068-5
Publikováno v:
Journal of Immunological Methods. 231:239-248
Angiogenesis, the formation of new blood vessels from pre-existing ones, is a characteristic process which underlies many diseases, including cancer, rheumatoid arthritis and blinding ocular disorders. Antibodies capable of selective targeting and oc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2010dca049354be6eaaa7f377805e2f
https://doi.org/10.1016/s0022-1759(99)00160-x
https://doi.org/10.1016/s0022-1759(99)00160-x
Publikováno v:
European journal of nuclear medicine. 28(4)
Angiogenesis is a characteristic feature of many aggressive tumours and other disorders. Antibodies capable of binding to new blood vessels, but not to mature vessels, could be used as selective targeting agents for immunoscintigraphic and radioimmun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5ae9941bebd9915cd7979ce710d5038
https://pubmed.ncbi.nlm.nih.gov/11357506
https://pubmed.ncbi.nlm.nih.gov/11357506
Autor:
Luciano Zardi, Alessandro Pini, Ahuva Nissim, Greg Winter, Lorenzo Tarli, Germano Querzé, Enrica Balza, Barbara Carnemolla, Dario Neri, Cornelia Halin, Alessandra Leprini, Paolo Neri
Publikováno v:
Nature biotechnology. 15(12)
The oncofetal fibronectin (B-FN) isoform is present in vessels of neoplastic tissues during angiogenesis but not in mature vessels. B-FN could therefore provide a target for diagnostic imaging and therapy of cancer. Phage display libraries have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28211f64daf4ed3bfe1c4fda8d88675b
https://pubmed.ncbi.nlm.nih.gov/9359110
https://pubmed.ncbi.nlm.nih.gov/9359110